Mechanism of Action: GLP-1 receptor agonists work through multiple physiological pathways: Central appetite suppression : These medications cross the blood-brain barrier and activate GLP-1 receptors in the hypothalamus and brainstem, reducing hunger signals and increasing satiety Gastric emptying delay : By slowing stomach emptying, patients experience prolonged fullness after meals Insulin secretion enhancement : Glucose-dependent insulin release improves glycemic control Glucagon suppression : Reduced glucagon secretion decreases hepatic glucose production Tirzepatide offers dual agonism at both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, potentially providing enhanced weight loss efficacy compared to single-agonist medications
That includes whole-grain rice, oatmeal, beans, and broccoli
NAION was not reported as an adverse event in trials studying semaglutide
SaveOn SP Express Scripts program SaveOnSP is designed to help you save money on certain specialty medications for those taking a medication on the SaveOnSP Drug list, and are eligible for the program
Before stopping any medication, obtain clearance from your prescribing healthcare provider
Tirzepatide reduces appetite, energy intake, and fat mass in people with T2D (abstract)
